Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis

Circulation
Kenji OnoueYoshihiko Saito

Abstract

Renal dysfunction is commonly accompanied by a worsening of atherosclerosis; however, the underlying molecular mechanism is not fully understood. We examined the role played by soluble fms-like tyrosine kinase-1 (sFlt-1), an endogenous antagonist of the proatherogenic cytokine placental growth factor (PlGF), in the worsening of atherosclerosis in patients with renal dysfunction and in an animal model of renal failure. In this study, 329 patients who received cardiac catheterization and 76 patients who underwent renal biopsy were enrolled. Both plasma sFlt-1 levels and renal sFlt-1 mRNA expression were positively correlated with estimated glomerular filtration rate (P<0.01). The PlGF/sFlt-1 ratio was negatively correlated with estimated glomerular filtration rate (P<0.01), whereas plasma PlGF levels were not affected by it. The PlGF/sFlt-1 ratio was significantly higher in patients with multivessel coronary artery disease than in patients with single-vessel or no coronary artery disease. The reduction of circulating sFlt-1 and renal sFlt-1 mRNA levels was confirmed in five-sixths (5/6)-nephrectomized apolipoprotein E-deficient mice that developed experimental renal dysfunction. Atherosclerotic plaque area and macrophage infiltra...Continue Reading

References

Feb 1, 1983·The American Journal of Cardiology·G G Gensini
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K G PetersL T Williams
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R L Kendall, K A Thomas
Sep 17, 1998·The New England Journal of Medicine·C A HerzogA J Collins
Jun 23, 2000·Journal of the American Society of Nephrology : JASN·Stephen ThomasGiancarlo Viberti
Aug 21, 2002·Circulation·Jassim Al SuwaidiUNKNOWN PARAGON-A Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organi
Oct 2, 2002·Annals of Internal Medicine·R Scott WrightAllan S Jaffe
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Kaori KogaYuji Taketani
Sep 30, 2003·Journal of the American Society of Nephrology : JASN·Susanne BroLars B Nielsen
Feb 7, 2004·The New England Journal of Medicine·Richard J LevineS Ananth Karumanchi
Sep 24, 2004·The New England Journal of Medicine·Nagesh S AnavekarMarc A Pfeffer
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Feb 22, 2007·Journal of Cellular Physiology·Carsten VogelSilvia Fischer
Jun 27, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Shuhei YoshimotoYoshihiko Saito
Jul 4, 2007·Circulation·Ernesto L SchiffrinJohannes F E Mann
Nov 8, 2007·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR

❮ Previous
Next ❯

Citations

Sep 3, 2011·PloS One·David M CharytanElisabeth M Zeisberg
Jun 19, 2013·International Heart Journal·Ryo KamedaTohru Izumi
Apr 15, 2014·Journal of Atherosclerosis and Thrombosis·Masayuki KoizumiToshisuke Morita
May 5, 2012·Purinergic Signalling·Herbert ZimmermannNorbert Sträter
Apr 1, 2011·Journal of Pharmaceutical Sciences·Harry G Brittain
Mar 16, 2011·Renal Failure·Oskar ZakiyanovVladimír Tesař
Jun 26, 2018·International Journal of Molecular Sciences·Katsuyuki TanabeJun Wada
Dec 28, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuki NakadaYoshihiko Saito
Mar 20, 2015·Journal of the American Society of Nephrology : JASN·Masaru MatsuiUNKNOWN NARA-CKD Investigators
Aug 1, 2013·Physiological Reviews·Paul N Hopkins
Aug 7, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Sanghoon ShinYangsoo Jang
Sep 15, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Burak PamukcuGregory Y H Lip
Apr 28, 2018·International Journal of Molecular Sciences·Cristina M FaillaVeronica Morea
Jul 3, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Hiroyuki KawahitoHiroaki Matsubara
Oct 13, 2020·Journal of Molecular and Cellular Cardiology·Yoshihiko Saito
Jun 23, 2021·Journal of the American Society of Nephrology : JASN·Theresa M WewersGiovana S Di Marco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.